These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 33905285)

  • 21. Chemotherapy-Induced Peripheral Neuropathy Impacts Quality of Life and Activities of Daily Living of Brazilian Multiple Myeloma Patients.
    de Miranda Drummond PL; Dos Santos RMM; Silveira LP; Malta JS; Moreira Reis AM; Costa NL; de Paula E Silva RO; Fagundes EM; de Pádua CAM
    Curr Drug Saf; 2024; 19(3):356-367. PubMed ID: 37592770
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Disease burden and pain in obese cancer patients with chemotherapy-induced peripheral neuropathy.
    Cox-Martin E; Trahan LH; Cox MG; Dougherty PM; Lai EA; Novy DM
    Support Care Cancer; 2017 Jun; 25(6):1873-1879. PubMed ID: 28124735
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development and validation of the comprehensive assessment scale for chemotherapy-induced peripheral neuropathy in survivors of cancer.
    Kanda K; Fujimoto K; Mochizuki R; Ishida K; Lee B
    BMC Cancer; 2019 Sep; 19(1):904. PubMed ID: 31506070
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Redefining chemotherapy-induced peripheral neuropathy through symptom cluster analysis and patient-reported outcome data over time.
    Wang M; Cheng HL; Lopez V; Sundar R; Yorke J; Molassiotis A
    BMC Cancer; 2019 Nov; 19(1):1151. PubMed ID: 31775665
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chemotherapy-induced neuropathy and pain in pediatric oncology patients: impact of combination therapies.
    Soriano D; Santos Chocler G; Varela MA; Coronel MF
    Eur J Pediatr; 2024 Sep; 183(9):3749-3756. PubMed ID: 38856761
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A randomised, placebo-controlled trial assessing the efficacy of an oral B group vitamin in preventing the development of chemotherapy-induced peripheral neuropathy (CIPN).
    Schloss JM; Colosimo M; Airey C; Masci P; Linnane AW; Vitetta L
    Support Care Cancer; 2017 Jan; 25(1):195-204. PubMed ID: 27612466
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The association of chemotherapy-induced peripheral neuropathy with reduced executive function in chemotherapy-treated cancer survivors: A cross-sectional study.
    McNeish BL; Dittus K; Mossburg J; Krant N; Steinharter JA; Feb K; Cote H; Hehir MK; Reynolds R; Redfern MS; Rosano C; Richardson JK; Kolb N
    J Geriatr Oncol; 2024 May; 15(4):101765. PubMed ID: 38581957
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exploring the efficacy of an electronic symptom assessment and self-care intervention to preserve physical function in individuals receiving neurotoxic chemotherapy.
    Knoerl R; Weller E; Halpenny B; Berry D
    BMC Cancer; 2018 Dec; 18(1):1203. PubMed ID: 30514351
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reference values for the EORTC QLQ-C30 in patients with advanced stage Hodgkin lymphoma and in Hodgkin lymphoma survivors.
    Vachon H; Mierzynska J; Taye M; Pe M; Coens C; Martinelli F; Fortpied C; Flechtner HH; Vestmoe Maraldo M; Hutchings M; Meijnders P; Aleman B; Lugtenburg P; Spina M; André M; Hertzberg M; Briones J; Bottomley A;
    Eur J Haematol; 2021 May; 106(5):697-707. PubMed ID: 33570765
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acupuncture for Chemotherapy-Induced Peripheral Neuropathy in Breast Cancer Survivors: A Randomized Controlled Pilot Trial.
    Lu W; Giobbie-Hurder A; Freedman RA; Shin IH; Lin NU; Partridge AH; Rosenthal DS; Ligibel JA
    Oncologist; 2020 Apr; 25(4):310-318. PubMed ID: 32297442
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of Chemotherapy-Induced Peripheral Neuropathy in Women With Breast Cancer: A Structural Equation Approach With the Theory of Unpleasant Symptoms.
    Kim M; Jung MS
    Cancer Nurs; 2021 Mar-Apr 01; 44(2):145-153. PubMed ID: 31833921
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anxiety and depression mediate the association between chemotherapy-induced peripheral neuropathy and fatigue: Results from the population-based PROFILES registry.
    Bonhof CS; van de Poll-Franse LV; Vissers PAJ; Wasowicz DK; Wegdam JA; Révész D; Vreugdenhil G; Mols F
    Psychooncology; 2019 Sep; 28(9):1926-1933. PubMed ID: 31293046
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The impact of treatment, socio-demographic and clinical characteristics on health-related quality of life among Hodgkin's and non-Hodgkin's lymphoma survivors: a systematic review.
    Oerlemans S; Mols F; Nijziel MR; Lybeert M; van de Poll-Franse LV
    Ann Hematol; 2011 Sep; 90(9):993-1004. PubMed ID: 21670973
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chemotherapy induced peripheral neuropathy: the modified total neuropathy score in clinical practice.
    Vasquez S; Guidon M; McHugh E; Lennon O; Grogan L; Breathnach OS
    Ir J Med Sci; 2014 Mar; 183(1):53-8. PubMed ID: 23832573
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of electrochemical skin conductance with neuropathy in chemotherapy-treated patients.
    Mahfouz FM; Park SB; Li T; Timmins HC; Horvath LG; Harrison M; Grimison P; King T; Goldstein D; Mizrahi D
    Clin Auton Res; 2022 Dec; 32(6):497-506. PubMed ID: 36129622
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Longitudinal validation and comparison of the Chinese version of the European Organization for Research and Treatment of Cancer Quality of Life-Chemotherapy-Induced Peripheral Neuropathy Questionnaire (EORTC QLQ-CIPN20) and the Functional Assessment of Cancer-Gynecologic Oncology Group-Neurotoxicity subscale (FACT/GOG-Ntx).
    Cheng HL; Molassiotis A
    Asia Pac J Clin Oncol; 2019 Feb; 15(1):56-62. PubMed ID: 29873180
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of Chemotherapy-Induced Peripheral Neuropathy on Quality of Life in Patients with Advanced Lung Cancer Receiving Platinum-Based Chemotherapy.
    Hung HW; Liu CY; Chen HF; Chang CC; Chen SC
    Int J Environ Res Public Health; 2021 May; 18(11):. PubMed ID: 34073174
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence of slow and variable choice-stepping reaction time in cancer survivors with chemotherapy-induced peripheral neuropathy.
    Menant JC; Goldstein D; Au K; Trinh T; van Schooten KS; McCrary JM; Harris CA; Forster BC; Park SB
    Gait Posture; 2021 Sep; 89():178-185. PubMed ID: 34320441
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Association of Chemotherapy-Induced Peripheral Neuropathy Symptoms and the Risk of Falling.
    Kolb NA; Smith AG; Singleton JR; Beck SL; Stoddard GJ; Brown S; Mooney K
    JAMA Neurol; 2016 Jul; 73(7):860-6. PubMed ID: 27183099
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Physical activity behaviors in cancer survivors treated with neurotoxic chemotherapy.
    Mizrahi D; Goldstein D; Trinh T; Li T; Timmins HC; Harrison M; Marx GM; Hovey EJ; Lewis CR; Friedlander M; Park SB
    Asia Pac J Clin Oncol; 2023 Feb; 19(1):243-249. PubMed ID: 35879821
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.